VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,145,000 | -20.5% | 1,301,350 | +12.1% | 0.70% | -9.4% |
| Q1 2022 | $1,440,000 | -26.3% | 1,161,350 | +15.9% | 0.77% | -25.7% |
| Q4 2021 | $1,955,000 | -22.1% | 1,002,350 | +9.4% | 1.04% | -9.9% |
| Q3 2021 | $2,510,000 | -14.6% | 916,100 | -1.8% | 1.16% | -21.4% |
| Q2 2021 | $2,939,000 | +56.4% | 932,956 | +5.8% | 1.47% | +36.9% |
| Q1 2021 | $1,879,000 | – | 881,956 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|